News

LZVO (Latvijas Zāļu verifikācijas organizācija) releases newsletter No. 8, where you can find the most important information about events in the world of pharmaceutical verification in 2024 as well on the previous five years. Also our neighbors in Estonia sharing their experience story.

The European Medicines Verification System, operating since 2019 in accordance with the EU Directive and Delegated Regulation, is a comprehensive, pan-European system covering all EU and EEA countries, connecting 2,800 pharmaceutical companies, 4,000 wholesalers, 110,000 pharmacies and 6,000 hospital pharmacies online, including all Latvian end users.

February 9, 2024, will mark 5 years since operations of a medicine verification system began across Europe and Latvia. The system’s purpose is to ensure that all people receive only safe medicines, eliminating the possibility of counterfeit drugs reaching patients through legal supply chains. Over time, the number of checked and decommissioned medicine packages in the Latvian Medicine Verification System (Latvijas zāļu verifikācijas sistēma – LZVS) has gradually increased, the proportion of alerts has decreased, and the LZVS end user registration system has been fully sorted.

Kamēr Eiropā turpinās izmeklēšana Ozempic gadījumā, arī ASV Pārtikas un zāļu pārvalde (FDA) turpina izmeklēt viltotu Ozempic (semaglutīda) injekciju 1 miligramu (mg) likumīgajā ASV zāļu piegādes ķēdē un ir konfiscējusi tūkstošiem produkta vienību.

The system is well accepted and implemented by all end users and by the Estonian NCA. The following is a brief overview of the different ways in which packaging is checked in Estonia and the way in which alerts are managed.

On November 27, 2023, a General Assembly meeting of stakeholders of the Latvian Medicines Verification Organisation (LZVO) was held, where the strategy and budget for 2024 were approved.